Category: Drug Development
Drug Development market research reports by GlobalData
-
Drug Development Trends in China
Drug Development Trends in China Summary China has emerged as a critical player in global drug development, driven by robust innovation. The pharmaceutical industry in China has seen a surge in drug development activities in recent years, with an increasing focus on innovative therapies such as CAR- ... Read More
-
Strategic Intelligence: AI in drug discovery
Strategic Intelligence: AI in drug discovery Summary In recent years, the pharma industry has been taken over by a wave of digital transformation, leading to the integration of advanced technologies across different aspects of the pharma value chain. Artificial intelligence (AI) and big data are at ... Read More
-
Esophageal Cancer: Competitive Landscape
Esophageal Cancer: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. In 2024, more than 410,000 diagnosed incident cases of EC are anticipated in the 16 countries covered in GlobalData’s epide ... Read More
-
Global Biosensors
Global Biosensors Summary Global Biosensors industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial ... Read More
-
Biosensors in Europe
Biosensors in Europe Summary Biosensors in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key fin ... Read More
-
Biosensors in Middle East & Africa
Biosensors in Middle East & Africa Summary Biosensors in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key ... Read More
-
Biosensors in Asia-Pacific
Biosensors in Asia-Pacific Summary Biosensors in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players inclu ... Read More
-
Biosensors in North America
Biosensors in North America Summary Biosensors in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players inc ... Read More
-
Biosensors in South America
Biosensors in South America Summary Biosensors in South America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key fin ... Read More
-
AI in Healthcare - Thematic Intelligence
AI in Healthcare - Thematic Intelligence Summary Artificial intelligence (AI) is a fast-growing industry. GlobalData expects every segment of the AI market to grow over the next decade. According to GlobalData forecasts, the AI market was worth $103 billion in 2023. By 2030, it will have grown at ... Read More
-
Pharmaceutical Drug Development Annual Review - 2023
Pharmaceutical Drug Development Annual Review - 2023 Summary This report investigates the year 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based ana ... Read More
-
Thematic Intelligence: Rare Disease
Thematic Intelligence: Rare Disease Summary In recent years, there has been growing recognition of the importance of rare diseases as a global health priority, leading to increased research efforts, policy initiatives, and collaborative partnerships aimed at accelerating progress in this field. Key ... Read More
-
Looking Ahead to 2024 - the Future of Pharma
Looking Ahead to 2024 - the Future of Pharma Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, an ... Read More
-
New Prescription - Generative AI meets Healthcare (Vol. 2)
New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More
-
Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success
Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success Summary This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements ... Read More
-
Startup Series - Tech, genes, and beyond - transforming biotech
Startup Series - Tech, genes, and beyond - transforming biotech Summary Biotechnology is crucial in solving global challenges and enhancing human well-being in medicine, agriculture, and environmental sustainability. Startups are leading the way, driven by healthcare demands, government support, and ... Read More
-
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Ewing Sarcoma therapeutics. There will be only 9,457 diagnosed prevalent cases of ES in 2023 in the ... Read More
-
Generative Artificial Intelligence (AI) Meets Healthcare - New Prescription
Generative Artificial Intelligence (AI) Meets Healthcare - New Prescription Summary Pharma and healthcare sectors are getting a tech makeover with generative AI. From crunching massive data sets for R&D breakthroughs to mimicking human speech for improved patient care, this technology is making wave ... Read More
-
Future of Pharma - Looking Ahead to 2023
Future of Pharma - Looking Ahead to 2023 Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and mar ... Read More
-
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in bladder cancer therapeutics. Synopsis In 2022, there will be more than 460,000 diagnosed incident c ... Read More
-
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022 Summary This report contains a summary of the analyst consensus forecasts available in the GlobalData Pharma Intelligence Center Drug Sales and Analyst Consensus Database for the Indication COVID-19. Currently ... Read More
-
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in NSCLC therapeutics. Synopsis In 2022, there will be more than 1.5 million diagnosed pre ... Read More
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. Synopsis In 2022, there will be more than 440,000 diagnosed prev ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022 Summary The Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer looks at the data from clinical trials for vaccines and therapeutics either currently marketed or in the pipeline. The data is assessed, ... Read More
-
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Genomics Landscape Continues to Be Dynamic in Q2 2022 With Less Activity Seen in Immuno-oncology. The genomics landscape was active in Q2 2022, with scores increased for several companies. This includes ... Read More
Research Assistance
